511 filings
Page 3 of 26
8-K
PBLA
Panbela Therapeutics, Inc.
1 Dec 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
UPLOAD
PBLA
Panbela Therapeutics, Inc.
28 Nov 23
Letter from SEC
12:00am
DEF 14A
PBLA
Panbela Therapeutics, Inc.
Definitive proxy
24 Nov 23
4:30pm
S-1
PBLA
Panbela Therapeutics, Inc.
IPO registration
22 Nov 23
5:01pm
D
PBLA
Panbela Therapeutics, Inc.
17 Nov 23
Indefinite amount in equity / options, sold $3.32 mm, 3 investors
5:10pm
PRE 14A
PBLA
Panbela Therapeutics, Inc.
Preliminary proxy
14 Nov 23
5:25pm
4
PBLA
Panbela Therapeutics, Inc.
13 Nov 23
Change in insider ownership
7:29pm
3
PBLA
Panbela Therapeutics, Inc.
13 Nov 23
Initial statement of insider ownership
7:27pm
10-Q
2023 Q3
PBLA
Panbela Therapeutics, Inc.
Quarterly report
9 Nov 23
4:15pm
8-K
PBLA
Panbela Therapeutics, Inc.
9 Nov 23
Panbela Provides Business Update and Reports Q3 2023 Financial Results
4:10pm
DEFA14A
PBLA
Panbela Therapeutics, Inc.
3 Nov 23
Additional proxy soliciting materials
5:25pm
8-K
PBLA
Panbela Therapeutics, Inc.
3 Nov 23
Entry into a Material Definitive Agreement
5:24pm
4
PBLA
Panbela Therapeutics, Inc.
14 Sep 23
Panbela Therapeutics / Jeffrey E. Jacob ownership change
4:06pm
10-Q
2023 Q2
PBLA
Panbela Therapeutics, Inc.
Quarterly report
10 Aug 23
4:15pm
8-K
PBLA
Panbela Therapeutics, Inc.
10 Aug 23
Panbela Provides Business Update and Reports Q2 2023 Financial Results
4:11pm
8-K
PBLA
Panbela Therapeutics, Inc.
19 Jul 23
Regulation FD Disclosure
8:02am
8-K
PBLA
Panbela Therapeutics, Inc.
10 Jul 23
Regulation FD Disclosure
4:15pm
8-K
PBLA
Panbela Therapeutics, Inc.
21 Jun 23
Panbela Announces Pricing of Approximately $8.5 Million Public Offering
5:00pm
424B4
PBLA
Panbela Therapeutics, Inc.
20 Jun 23
Prospectus supplement with pricing info
5:19pm
EFFECT
PBLA
Panbela Therapeutics, Inc.
16 Jun 23
Notice of effectiveness
12:15am